Knowledge is power? Cervical cancer prevention in female OB/GYNs compared to other female physicians
- PMID: 37780452
- PMCID: PMC10540616
- DOI: 10.3389/fpubh.2023.1269393
Knowledge is power? Cervical cancer prevention in female OB/GYNs compared to other female physicians
Abstract
Cervical cancer (CC) screening and prevention are crucial responsibilities of obstetrician-gynecologists (OB/GYNs). Our study aimed to investigate whether knowledge impacts OB/GYNs' (n = 42) adherence to CC prevention measures by comparing them to non-OB/GYN physicians (n = 80). An anonymous questionnaire collected demographic information, personal screening habits and evaluated their knowledge of CC prevention. Results revealed that OB/GYNs exhibited superior knowledge of CC risk factors and prevention compared to non-OB/GYNs. Of note, a lower percentage of OB/GYN residents correctly identified the recommended upper age limit for cervical screening and for HPV vaccination compared to attending OB/GYNs (50% vs. 83%, p = 0.04 and 11% vs. 50%, p = 0.01, respectively). Despite these findings, most physicians from both groups recommended HPV vaccination. Cervical screening rates were similar between OB/GYNs and non-OB/GYNs (75% vs. 83%, p = 0.3). Half of OB/GYNs initiated their own cervical screening, similar to non-OB/GYNs. Interestingly, residents had higher HPV vaccination rates compared to attending physicians, irrespective of specialty (OB/GYNs - 38.89% vs. 4.76%, p = 0.0149; non-OB/GYNs - 51.06% vs. 15.38%, p = 0.0028). In conclusion, contrary to the assumption that physicians prioritize personal well-being, our study reveals the opposite. While skilled in guiding patients through CC screening and prevention, female OB/GYNs often neglect their own health. OB/GYNs must also be educated and supported in safeguarding their health, setting an essential example for patients.
Keywords: HPV vaccine; OB/GYN; cervical cancer; cervical screening; female physicians; prevention.
Copyright © 2023 Hershkovitz, Ochshorn, Michaan, Fiszer, Grisaru and Raz.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Knowledge, Attitude, and Practice of Cervical Cancer Screening, and HPV Vaccination: A Cross-Sectional Study Among Obstetricians and Gynecologists in Egypt.Matern Child Health J. 2022 Mar;26(3):565-574. doi: 10.1007/s10995-021-03352-8. Epub 2022 Jan 21. Matern Child Health J. 2022. PMID: 35060068
-
Providers' practice, recommendations and beliefs about HPV vaccination and their adherence to guidelines about the use of HPV testing, 2007 to 2010.Prev Med. 2016 Jun;87:128-131. doi: 10.1016/j.ypmed.2016.02.030. Epub 2016 Feb 26. Prev Med. 2016. PMID: 26921654 Free PMC article.
-
Improving Knowledge and Awareness of Human Papillomavirus-Associated Gynecologic Cancers: Results from the National Comprehensive Cancer Control Program/Inside Knowledge Collaboration.J Womens Health (Larchmt). 2018 Aug;27(8):955-964. doi: 10.1089/jwh.2018.7289. J Womens Health (Larchmt). 2018. PMID: 30129896 Free PMC article.
-
Infrastructure requirements for human papillomavirus vaccination and cervical cancer screening in sub-Saharan Africa.Vaccine. 2013 Dec 29;31 Suppl 5:F47-52. doi: 10.1016/j.vaccine.2012.06.066. Vaccine. 2013. PMID: 24331747 Review.
-
Clinicians' attitude towards changes in Australian National Cervical Screening Program.J Clin Virol. 2016 Mar;76 Suppl 1:S81-S87. doi: 10.1016/j.jcv.2015.11.018. Epub 2015 Nov 19. J Clin Virol. 2016. PMID: 26651602 Review.
Cited by
-
Actions speak louder than words; pediatricians, gynecologists, nurses, and other mothers' perspectives on the human papillomavirus vaccine: an Istanbul multicenter study.Front Public Health. 2024 May 2;12:1361509. doi: 10.3389/fpubh.2024.1361509. eCollection 2024. Front Public Health. 2024. PMID: 38756889 Free PMC article.
References
-
- Berrington de González A, Green J, I.C.O.E.S.O.C . Cancer, comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. (2007) 120:885–91. doi: 10.1002/ijc.22357 - DOI - PubMed
-
- Singh D, Vignat J, Lorenzoni V, Eslahi M, Ginsburg O, Lauby-Secretan B, et al. . Global estimates of incidence and mortality of cervical cancer in 2020: a baseline analysis of the WHO global cervical Cancer elimination initiative. Lancet Glob Health. (2023) 11:e197–206. doi: 10.1016/S2214-109X(22)00501-0, PMID: - DOI - PMC - PubMed